155 related articles for article (PubMed ID: 9139613)
1. [Cellular oncogenes and antioncogenes in thyroid tumors].
Abrosimov AIu
Arkh Patol; 1997; 59(1):64-9. PubMed ID: 9139613
[TBL] [Abstract][Full Text] [Related]
2. Molecular biology of thyroid neoplasms.
Satta MA; Nanni S; Della Casa S; Pontecorvi A
Rays; 2000; 25(2):151-61. PubMed ID: 11370534
[TBL] [Abstract][Full Text] [Related]
3. Absence of activating mutations in ras and gsp oncogenes in a cohort of nine patients with sporadic pediatric thyroid tumors.
Pauws E; Tummers RF; Ris-Stalpers C; de Vijlder JJ; Voûte T
Med Pediatr Oncol; 2001 Jun; 36(6):630-4. PubMed ID: 11344494
[TBL] [Abstract][Full Text] [Related]
4. Oncogenes and antioncogenes involved in human thyroid carcinogenesis.
Lazzereschi D; Mincione G; Coppa A; Ranieri A; Turco A; Baccheschi G; Pelicano S; Colletta G
J Exp Clin Cancer Res; 1997 Sep; 16(3):325-32. PubMed ID: 9387909
[TBL] [Abstract][Full Text] [Related]
5. Genetics of follicular thyroid cancer.
Farid NR; Zou M; Shi Y
Endocrinol Metab Clin North Am; 1995 Dec; 24(4):865-83. PubMed ID: 8608782
[TBL] [Abstract][Full Text] [Related]
6. [The role of genetic factors in the pathogenesis of thyroid neoplasms].
Ferenc T; Maciaszczyk K; Gesing A; Lewiński A
Postepy Hig Med Dosw; 1997; 51(4):367-84. PubMed ID: 9446100
[TBL] [Abstract][Full Text] [Related]
7. Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells.
Ivan M; Bond JA; Prat M; Comoglio PM; Wynford-Thomas D
Oncogene; 1997 May; 14(20):2417-23. PubMed ID: 9188856
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology and etiology of differentiated thyroid carcinoma.
Busnardo B; De Vido D
Biomed Pharmacother; 2000 Jul; 54(6):322-6. PubMed ID: 10989966
[TBL] [Abstract][Full Text] [Related]
9. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
10. ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.
Garcia-Rostan G; Zhao H; Camp RL; Pollan M; Herrero A; Pardo J; Wu R; Carcangiu ML; Costa J; Tallini G
J Clin Oncol; 2003 Sep; 21(17):3226-35. PubMed ID: 12947056
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis of thyroid nodules and cancer.
Moretti F; Nanni S; Pontecorvi A
Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):517-39. PubMed ID: 11289733
[TBL] [Abstract][Full Text] [Related]
12. Oncogenes and suppressor genes: their involvement in colon cancer.
Rigas B
J Clin Gastroenterol; 1990 Oct; 12(5):494-9. PubMed ID: 2229991
[TBL] [Abstract][Full Text] [Related]
13. [Molecular basis of tumors arising in thyroid follicular cells].
Wynford-Thomas D
Ann Chir; 1999; 53(3):237-43. PubMed ID: 10339867
[TBL] [Abstract][Full Text] [Related]
14. An overview of molecular abnormalities leading to thyroid carcinogenesis: a 1993 perspective.
Gagel RF
Stem Cells; 1997; 15 Suppl 2():7-13. PubMed ID: 9368282
[TBL] [Abstract][Full Text] [Related]
15. [Identification of oncogenes and anti-oncogenes].
Thomas G
Pathol Biol (Paris); 1995 Mar; 43(3):143-9. PubMed ID: 7675540
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic dysregulation in thyroid neoplasia.
Kondo T; Asa SL; Ezzat S
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant.
Di Cristofaro J; Marcy M; Vasko V; Sebag F; Fakhry N; Wynford-Thomas D; De Micco C
Hum Pathol; 2006 Jul; 37(7):824-30. PubMed ID: 16784981
[TBL] [Abstract][Full Text] [Related]
18. [Progress in oncogene and antioncogene research].
Toyoshima K; Akiyama T
Gan To Kagaku Ryoho; 1992 Jun; 19(6):751-6. PubMed ID: 1351383
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of RAS point mutations in papillary thyroid carcinoma; a novel mutation at codon 31 of K-RAS.
Cyniak-Magierska A; Brzeziańska E; Januszkiewicz-Caulier J; Jarzab B; Lewiński A
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):594-9. PubMed ID: 17943694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
